Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
16.33%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 10.63M | 16.33% | $ 65.08M |
| 3/31/2025 | $ 10.86M | 6.05% | $ 179.64M |
| 12/31/2024 | $ 11.22M | 6.31% | $ 178.03M |
| 9/30/2024 | $ 11.26M | 6.43% | $ 175.04M |
| 6/30/2024 | $ 11.34M | 8.01% | $ 141.46M |
| 3/31/2024 | $ 10.82M | 58.97% | $ 18.36M |
| 12/31/2023 | $ 9.84M | 16.32% | $ 60.28M |
| 9/30/2023 | $ 8.41M | 11.83% | $ 71.08M |
| 6/30/2023 | $ 7M | 9.9% | $ 70.77M |
| 3/31/2023 | $ 6.33M | 8.89% | $ 71.17M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) DepAmor % stands at 250.06%.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average DepAmor % has been 64.35%.
- The median DepAmor % for ADAPTIMMUNE THERAPEUTICS PLC during this period was 30.78%
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest DepAmor % over the past 5 years at 250.06%.
- The lowest DepAmor % recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe 6.05%
ADAPTIMMUNE THERAPEUTICS PLC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: DepAmor [ $ 7.96M ] / Revenues [ $ 3.18M ]
(=) DepAmor % [ 250.06% ] ADAP - Depreciation and Amortization Margin, Last 5 years
6.05%
Minimum
Mar 31, 2025
250.06%
Maximum
Sep 30, 2020
64.35%
Average
30.78%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |